Impel NeuroPharma IPO

Impel NeuroPharma is a biotechnology company devoted to creating life-changing, innovative therapies for central nervous system (CNS) diseases.

Total Funding to Date$122.85MM
Register for Details

For more details on financing and valuation for Impel NeuroPharma, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Impel NeuroPharma Ticker Symbol


Impel NeuroPharma Stock Price

$2.94 as of 12/2/22